Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 2NIH 2OTHER_GOV 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Small Cell Lung Carcinoma 1Multiple Myeloma 1Meningioma 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Kidney Neoplasms 1Carcinoma, Renal Cell 1Breast Neoplasms, Male 1Breast Neoplasms 1Advanced Rare Tumours 1

Interventions

Cisplatin 3Taxes 2Psychiatric Rehabilitation 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Etoposide 2rubitecan 1pembrolizumab 1monalizumab 1marimastat 1etoposide phosphate 1durvalumab 1ceralasertib 1carfilzomib 1atezolizumab 1Watchful Waiting 1Sunitinib 1Specimen Handling 1Radiotherapy, Conformal 1Polymerase Chain Reaction 1Platinum Compounds 1PM 01183 1Nivolumab 1NK Cell Lectin-Like Receptor Subfamily C 1Mental Status and Dementia Tests 1Isotretinoin 1Irinotecan 1Ipilimumab 1Introns 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Small Cell Lung Carcinoma × Sunitinib × Clear all
NCT00953459 2018-07-26

Sunitinib Malate in Treating Patients With Small Cell Lung Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
9 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡